Company: SRPT
Filing Date: 2025-02-28
Form Type: 10-K
Source: 0000950170-25-029973
Chunk: 78

Company: Sarepta Therapeutics, Inc.
Filing Date: 2025-02-28
Form: 10-K
Item: Item 1B
Chunk 78
---
 26,887

        $
        29,620

       The in-licensed rights relate to agreements with UWA, Nationwide, BioMarin and PPMD. These in-licensed rights are being amortized on a straight-line basis over the remaining life of the related patent because the life of the related patent reflects the expected time period that the Company will benefit from the in-licensed rights. There were no additions of in-licensed rights during the year ended December 31, 2024. For more information related to the Company's in-licensed rights related to its license or settlement agreements with Nationwide, BioMarin and UWA, please refer to Note 3. License and Collaboration Agreements. For the years ended December 31, 2024, 2023 and 2022, the Company recorded $2.7 million, $1.9 million and $1.9 million, respectively, of amortization expense related to intangible assets.The following table summarizes the estimated future amortization for intangible assets: 

        As of December 31, 2024

        (in thousands)

        2025
         
        $
        2,648

        2026

        2,513

        2027

        2,444

        2028

        2,366

        2029

        1,957

        Thereafter

        14,959

        Total
         
        $
        26,887

F-26

12. ACCRUED EXPENSESThe following table summarizes the Company’s accrued expenses for each of the periods indicated: 

        As of December 31,

        2024

        2023

        (in thousands)

        Product revenue related reserves
         
        $
        109,157

        $
        100,075

        Accrued employee compensation costs

        91,119

        78,732

        Accrued contract manufacturing costs

        77,842

        33,024

        Accrued clinical and pre-clinical costs

        26,849

        34,669

        Accrued professional fees

        17,691

        17,187

        Accrued income taxes

        17,391

        13,766

        Accrued royalties

        16,625

        12,070

        Accrued fixed